UNIVERSITY OF ROCHESTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1850-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.rochester.edu
Deprescribing for Older Adults After Hospital Discharge in Home Health Care
- First Posted Date
- 2022-11-29
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 5
- Registration Number
- NCT05630144
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
Feasibility Study of the My Health Coach App for Adults With FASD
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-11-03
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 95
- Registration Number
- NCT05604014
- Locations
- 🇺🇸
Mt. Hope Family Center, Rochester, New York, United States
Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
- First Posted Date
- 2022-10-28
- Last Posted Date
- 2023-10-17
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 15
- Registration Number
- NCT05597345
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
Home Rehabilitation After Acute Pulmonary Embolism
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-10-07
- Last Posted Date
- 2024-02-09
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 80
- Registration Number
- NCT05571189
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-10-06
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 11279
- Registration Number
- NCT05570630
- Locations
- 🇺🇸
University of Rochester Medical Center (URMC), Rochester, New York, United States
A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer
Early Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-09-07
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 30
- Registration Number
- NCT05530655
- Locations
- 🇺🇸
Wilmot Cancer Institute, Rochester, New York, United States
Acceptability and Feasibility of Cognitive Behavioral Therapy for Treatment-Seeking (CBT-TS) With Deaf Individuals
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-08-29
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 42
- Registration Number
- NCT05520190
- Locations
- 🇺🇸
Aileen Aldalur, Rochester, New York, United States
Treatment of Post-partum Depression Using an Behavioral Intervention Called ROSE (Reach Out, Stay Strong, Essentials for Mothers of Newborns) Delivered Using an Electronic App
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-08-26
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 152
- Registration Number
- NCT05518162
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
Meningitis: Burden, Causes, Screening and Prevention in Rural Northern Uganda
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-08-11
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 11100
- Registration Number
- NCT05496673
- Locations
- 🇺🇬
Lira Regional Referral Hospital, Lira, Uganda
Team-Based Home Blood Pressure Monitoring
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-08-05
- Last Posted Date
- 2023-07-24
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 5760
- Registration Number
- NCT05488795
- Locations
- 🇺🇸
Highland Family Medicine, Rochester, New York, United States
© Copyright 2024. All Rights Reserved by MedPath